Quinlan Paul Tinsider trades
In SEC Form 4 filings, Quinlan Paul T is listed as General Counsel of Oruka Therapeutics, Inc. (ORKA). In the last 90 days, Quinlan Paul T sold $1.74M of Oruka Therapeutics, Inc. (ORKA) on the open market and bought none. 9 of the 10 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | General Counsel | 14 | Oct 20 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | M | 9,000 | $7.80 | $70,200 | 38,995 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | S | 400 | $74.90 | Sale −$29,960 | 38,595 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | S | 500 | $76.12 | Sale −$38,059 | 38,095 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | S | 1,000 | $77.21 | Sale −$77,205 | 37,095 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | S | 4,100 | $78.79 | Sale −$323,037 | 32,995 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | S | 3,000 | $79.49 | Sale −$238,474 | 29,995 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 20 | Oct 20 | M · derivative | 9,000 | $7.80 | $70,200 | 70,996 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | M | 10,000 | $7.80 | $78,000 | 39,995 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | S | 2,900 | $92.37 | Sale −$267,870 | 37,095 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | S | 3,832 | $93.32 | Sale −$357,592 | 33,263 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | S | 601 | $94.44 | Sale −$56,760 | 32,662 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | S | 2,667 | $95.31 | Sale −$254,196 | 29,995 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | M · derivative | 10,000 | $7.80 | $78,000 | 79,996 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 1,039 | $95.71 | Sale −$99,443 | 29,995 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.